Malcangi G, Fraticelli P, Palmieri C, Cappelli M, Danieli M G
Istituto di Clinica Medica, Ematologia ed Immunologia Clinica, Università di Ancona, Polo Didattico Scientifico, Torrette di Ancona, Italy.
Rheumatol Int. 2000 Dec;20(1):31-3. doi: 10.1007/s002960000066.
We report on a case of a 17-year-old female with systemic lupus erythematosus (SLE), with a clinical history of complex partial seizure, who developed a tonicoclonic crisis after receiving hydroxychloroquine for 2 weeks at a dosage of 200 mg/day (5 mg/kg). The absence of previous similar episodes and of recurrences after withdrawal of the drug in subsequent months, the short latency after administration and the favourable short-term evolution raised suspicions for a potential role of the drug in the development of the isolated convulsive crisis. It is possible for hydroxychloroquine to be responsible for tonicoclonic seizures in predisposed subjects.
我们报告了一例17岁系统性红斑狼疮(SLE)女性患者,有复杂部分性癫痫发作的临床病史,在接受羟氯喹2周,剂量为200mg/天(5mg/kg)后发生了强直阵挛性发作。既往无类似发作史,停药后数月也未复发,给药后潜伏期短且短期病情转归良好,这引发了对该药物在孤立性惊厥发作发展中潜在作用的怀疑。羟氯喹有可能导致易感人群发生强直阵挛性癫痫发作。